20 LATEST RESOURCES (52 INDEXED)
Guanfacine for Autism Spectrum Disorder, Attention-Deficit/Hyperactivity Disorder, and/or Oppositional Defiance Disorder · July 2022
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
OROS-Methylphenidate to Reduce ADHD Symptoms in Male Prisoners Aged 16-25 Years: A RCT · July 2022
Publications (Books-Reports)
National Institute for Health and Care Research
Predictions of Academic Performance of Children and Adolescents with ADHD Using the SHAP Approach (MEDINFO 2021: One World, One Health – Global Partnership for Digital Innovation) (Meetings-Events) · June 2022
Publications (Chapters)
IOS Press
Adult Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder: A Systematic Review of the Literature (ADHD: From Etiology to Comorbidity) · September 2020
Publications (Chapters)
IntechOpen Books
Society for Developmental and Behavioral Pediatrics Clinical Practice Guideline for the Assessment and Treatment of Children and Adolescents with Complex Attention-Deficit/Hyperactivity Disorder · February 2020
Publications (Guidelines)
Journal of Developmental and Behavioral Pediatrics
Repetitive Transcranial Magnetic Stimulation Treating Impulsivity in Borderline Personality Disorder and Attention Deficit/Hyperactivity Disorder (Transcranial Magnetic Stimulation in Neuropsychiatry) · September 2018
Publications (Chapters)
InTechOpen Books
Guanfacine Hydrochloride Extended-Release for the Treatment of Attention Deficit Hyperactivity Disorder in Adults: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines · September 2018
Publications (Books-Reports)
Canadian Agency for Drugs and Technologies in Health
Crossing the Divide: A Longitudinal Study of Effective Treatments for People with Autism and Attention Deficit Hyperactivity Disorder Across the Lifespan · June 2018
Publications (Books-Reports)
National Institute for Health Research
Attention Deficit Hyperactivity Disorder: Diagnosis and Management · March 2018
Publications (Books-Reports)
National Institute for Health and Care Excellence
Guanfacine Hydrochloride Extended-Release for Attention Deficit Hyperactivity Disorder: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines · March 2018
Publications (Guidelines)
Canadian Agency for Drugs and Technologies in Health
Cardiac Risk Assessment Before the Use of Stimulant Medications in Children and Youth (Position Statement) · February 2018
Publications (Books-Reports)
Canadian Paediatric Society
Extended-Release Medications for Children and Adolescents with Attention-Deficit Hyperactivity Disorder (Position Statement) · February 2018
Publications (Books-Reports)
Canadian Paediatric Society
Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment in Children and Adolescents (Comparative Effectiveness Review) · January 2018
Publications (Books-Reports)
Agency for Healthcare Research and Quality
Physician Office Visits for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents Aged 4-17 Years: United States, 2012-2013 · January 2017
Publications (Books-Reports)
CDC-NCHS National Center for Health Statistics Briefs
Pharmacologic Management of Patients with ADHD: Review of Guidelines · March 2016
Publications (Guidelines)
Canadian Agency for Drugs and Technologies in Health
High-Dose Stimulants for Attention Deficit Hyperactivity Disorder: A Review of the Clinical Effectiveness, Safety and Guidelines · March 2016
Publications (Guidelines)
Canadian Agency for Drugs and Technologies in Health
ADHD Medication Switching for Patients with Aggression or Mood Changes Secondary to Current Medication: Review of Clinical Effectiveness and Guidelines · September 2015
Publications (Guidelines)
Canadian Agency for Drugs and Technologies in Health
Prevalence of Attention Deficit Hyperactivity Disorders (Mental Disorders and Disabilities among Low-Income Children) · September 2015
Publications (Chapters)
National Academies Press
Diagnostic Experiences of Children with Attention-Deficit/Hyperactivity Disorder · September 2015
Publications (Books-Reports)
CDC-NCHS National Health Statistics Reports
Clinical Characteristics of Attention Deficit Hyperactivity Disorder (Mental Disorders and Disabilities among Low-Income Children) · September 2015
Publications (Chapters)
National Academies Press